Hypothalamic Damage Is Associated With Inflammatory Markers and Worse Cognitive Performance in Obese Subjects
Josep Puig(Institut d'Investigació Biomèdica de Girona), José Manuel Fernández‐Real(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition), Gerard Blasco(Institut d'Investigació Biomèdica de Girona), Salvador Pedraza(Hospital Clínic de Barcelona), Fernando Fernández‐Aranda(Massachusetts General Hospital), Gemma Xifra(Universitat de Girona), Pepus Daunis‐i‐Estadella(Universitat de Girona), Xavier Molina(Institut d'Investigació Biomèdica de Girona), Wifredo Ricart(Universitat de Girona)
Cited by 58
Related Papers
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
|Endocrine Reviews|2003|876
Perfusion-CT Assessment of Infarct Core and Penumbra
|Stroke|2006|771